Both external data calls returned disabled stubs. Per protocol I should still attempt the indicator step off the CSV — let me confirm whether get_indicators is available (it will depend on the CSV I was meant

Overall Sentiment: Mildly Bullish (Score: 5.9/10) Confidence: Low

Source-by-source breakdown (ARE, 2026-09-11 to 2026-09-18)

1. News (Yahoo Finance, past 7 days): unavailable — external market data tools disabled in this deployment. No news signal available in provided documents.

2. StockTwits (past 7 days): unavailable — external social data disabled in this deployment. No retail message flow or Bullish/Bearish ratio available in provided documents.

3. Reddit (r/wallstreetbets, r/stocks, r/investing): unavailable — external social data disabled in this deployment. No community discussion available in provided documents.

4. QuantOrb money-flow (FACTS, 2026-09-17 US session): ARE (Real Estate / Office REITs) shows MFI 67.02 with a CONTINUATION signal (strength 0.6251). This is a mildly-to-moderately constructive quantitative reading — elevated money flow with a trend-continuation bias — but it is a screen output, not a recommendation, and covers only a single session.

5. SEC filings:

6. 10-K (filed 2026-01-26): Establishes ARE as a life science REIT, S&P 500 member, market cap $20.75B as of 2025-12-31, 35.9M RSF operating plus 3.5M RSF Class A/A+ under construction across AAA clusters (Greater Boston, SF Bay Area, San Diego, Seattle, Maryland, Research Triangle, NYC). Framing is stable/defensive; no sentiment direction.
7. 8-K / 2Q26 press release (2026-08-03): Document exists (financial/operating results, guidance, FFO per share, dispositions, development pipeline sections) but only the table of contents is available — no actual figures. Contents "not available in provided documents."
8. 13F-HR (as of 2026-03-31, stale up to 45+ days): Mixed institutional positioning among the 5 tracked filers. Largest holder LaSalle trimmed -11.3% (-191,955 sh to 1,511,273); Analyst IMS trimmed -1.4%. Against this, three smaller holders added: Town Lane +15.5%, Oak Thistle +508.2% (118,913 sh added), Voss Capital +66.7%. Net read: modest rotation — large holder reducing, smaller funds accumulating. Small sample, not exhaustive, and stale relative to the 2026-09-11–18 window.

Cross-source divergences and alignments: The only live signal (QuantOrb CONTINUATION, MFI 67) aligns directionally with the smaller-fund accumulation seen in the 13F snapshot, while the largest tracked holder's reduction and the stale 13F data cut the other way. With all three real-time sentiment sources silent, no genuine cross-source confirmation is possible.

Dominant narrative themes: Life science real estate fundamentals and institutional positioning; no themes can be confirmed from the covered 7-day window.

Catalysts and risks: 2Q26 results were released 2026-08-03 (ahead of the window); 3Q26 results would be the next likely catalyst but are not dated in the provided documents. Risks: office/life science REIT sector pressures implied by the Office REITs classification; large-holder distribution (LaSalle trim); heavy reliance on a single-session quantitative signal.

Bottom line: The sentiment picture rests almost entirely on one quantitative money-flow reading plus stale, mixed 13F positioning — hence low confidence and only a mildly bullish lean. The trader should weigh this against fundamentals and technicals, not treat it as a price call.

ARE (Alexandria Real Estate Equities, Inc.) — News & Trend Research Report

Analysis date: 2026-09-18 | Instrument: ARE (NYSE: ARE) | Prepared for trading workflow

0. Data Availability Notice (read first)

All four assigned tools were called in parallel and returned NO_DATA_AVAILABLE: external market data tools are disabled in this deployment:

Accordingly, this report is built exclusively from the four source documents (QuantOrb money-flow snapshot, 10-K excerpt, 2Q26 8-K excerpt, 13F-HR snapshot). Anything not covered by them is flagged as "not available in provided documents." No prices, macro prints, news events, or probabilities have been fabricated.

1. Executive Summary

• The only evidence from the requested past-week window (2026-09-11 → 2026-09-18) is the QuantOrb money-flow snapshot for the 2026-09-17 US session: MFI 67.02, signal CONTINUATION, signal strength 0.6251. Company-specific news, global macro news, FRED indicators, and prediction-market odds for that window are not available in provided documents.
• The flow reading sits in the upper half of its 0–100 scale (67.02), and the engine's own label — CONTINUATION at 0.6251 strength — leans constructive on short-term flow persistence. Per the document itself, this is a quantitative screen output, not a recommendation.
• The freshest fundamental evidence is ~6.5 weeks old (2Q26 8-K, 2026-08-03); the excerpt contains only a table of contents, so no 2Q26 results, FFO, or guidance figures are quotable — specifics are not available in provided documents.
• Institutional 13F data (as of 2026-03-31) is ~5.5 months stale and covers only 5 tracked filers; within that subset the arithmetic nets to a modest accumulation (+80,412 shares, +2.3% of the tracked aggregate) — smaller funds added aggressively while the largest tracked holder trimmed.
• Bottom line for traders: the directional, time-relevant signal is mildly constructive on money flow, but it is a single, uncorroborated quantitative output standing against a stale fundamental record. Position sizing or entry levels cannot be responsibly derived — current price, volume, and valuation are not available in provided documents.

2. Past-Week News Canvas (2026-09-11 → 2026-09-18)

• Company-specific news for ARE: not available in provided documents. The only past-week datapoint is the QuantOrb engine snapshot (Section 3).
• Global / macroeconomic news: not available in provided documents. No Fed, CPI, geopolitics, or credit-market events for the window can be cited.
• Implication: the information environment for the past week consists of a single quantitative flow reading. Any trade taken on this window is effectively a bet on that signal alone, unconfirmed by narrative or macro context. Treat confirmation risk as unusually high.

3. ARE Quantitative Money-Flow Signal — the Core Past-Week Evidence

Source: QuantOrb money-flow engine, as of the 2026-09-17 US session (site bake of the 05:30 HKT orb run).

Interpretation (bounded by the document): - 67.02 on a 0–100 index places the reading in the upper portion of the scale — consistent with inflow-dominated trading during the most recent completed US session before this analysis. - The engine's own classification is CONTINUATION — i.e., it reads current flow conditions as likely to persist, not reverse. The strength parameter (0.6251) is above the midpoint of a 0–1 scale, implying moderate conviction; the document does not define the scale, so this is an arithmetic characterization only. - The document explicitly states this is a quantitative screen output, not a recommendation. It should be treated as a tactical, short-horizon tilt — not a thesis.

Trading read: If the desk trades flow signals at all, the 2026-09-17 bake supports a short-term constructive tilt on ARE, with the explicit caveat that (a) it is one session of evidence, (b) it is uncorroborated by any news, macro, or positioning data from the same window, and (c) no price/volume series is available to confirm what the flow is doing relative to trend.

4. Fundamental Profile (from filings)

4.1 Business profile — SEC 10-K (filed 2026-01-26; ~7.7 months old)

• Identity: Alexandria Real Estate Equities, Inc. (NYSE: ARE), S&P 500 constituent, Maryland corporation (formed Oct 1994), taxed as a REIT. Pioneer and "preeminent and longest-tenured" owner/operator/developer of life science real estate — Megacampus™ ecosystems in AAA life science innovation clusters: Greater Boston, SF Bay Area, San Diego, Seattle, Maryland, Research Triangle, New York City.
• Scale (as of December 31, 2025):
• Total market capitalization: $20.75 billion
• Operating properties: 35.9 million RSF
• Class A/A+ properties under construction: 3.5 million RSF
• Derived ratio (arithmetic on filed figures): under-construction pipeline ≈ 9.7% of the operating RSF base (3.5M / 35.9M). This is a materially development-weighted profile: as a REIT, funding and leasing that pipeline is a central execution and capital-markets dependency.
• Tenant exposure: excerpt confirms tenants include multinational pharmaceutical companies (list truncated in the document).
• MD&A note: the company uses disclosure exceptions and presents alternative disclosures in Item 7 — meaning conventional MD&A framing may be non-standard; the excerpt provides no further detail.

4.2 Most recent financial filing — SEC 8-K Item 2.02 (2026-08-03), quarter ended June 30, 2026

• The filing exists and its structure confirms the standing disclosure set: Financial and Operating Results, Guidance, Dispositions / Sales of Partial Interests / Other Capital Sources, FFO and FFO per Share, Consolidated Balance Sheets, plus a supplemental covering investments in real estate, new Class A/A+ development/redevelopment, Recent Deliveries, Under Construction, and the tenant base.
• Critically: the excerpt is a table of contents only. No 2Q26 revenue, FFO, FFO/share, guidance, occupancy, leasing, disposition, or balance-sheet figures are contained in the provided documents — all such specifics are not available in provided documents.
• The document is explicitly flagged as NOT an earnings call transcript — management commentary is therefore also not available in provided documents.
• Relevance for the desk: the most recent fundamental datapoint is now ~46 days old. The 2Q26 supplemental's structure confirms that dispositions and alternative capital sources are a standing, tracked disclosure line — any subsequent 8-K in that category is a primary catalyst to monitor for a REIT carrying a 3.5M RSF construction pipeline. The 3Q26 report date is not available in provided documents.

5. Institutional Positioning — 13F-HR (positions as of 2026-03-31; statutory lag up to 45 days; ~5.5 months stale at analysis date)

Scope caveat (per the document): 5 tracked filer rows only — not an exhaustive list of 13F filers holding ARE; a periodic regulatory snapshot, not real-time portfolio data.

Derived arithmetic (on the provided figures only): - Aggregate tracked position: 3,561,144 shares - Total shares added: +285,179 (Town Lane + Oak Thistle + Voss) - Total shares trimmed: −204,767 (Lasalle + IMS) - Net: +80,412 shares ≈ +2.3% of the tracked aggregate; buy-to-sell ratio ≈ 1.4:1 within this subset - Shape of the flow: the largest tracked holder trimmed (Lasalle, −11.3%) while smaller funds added aggressively — including a near-6x position build by Oak Thistle off a small base. This is a classic "size-divergent" pattern: base-building by smaller allocations against a trim by the biggest tracked name.

Trading read: Directionally mildly supportive, but with three heavy discounts: (1) the data is ~5.5 months old and predates the 2Q26 print; (2) it covers only 5 of an unknown universe of holders; (3) small-base percentage adds (e.g., +508.2%) are noisy. Use as color, not as signal.

6. Macro Backdrop for a REIT — What Matters and What Is Knowable

• Rate sensitivity (structural, not data): ARE is a REIT with a 9.7%-of-operating-RSF construction pipeline. REIT valuations discount long-duration cash flows and development programs depend on capital-markets access — so the Fed path, the 10-year Treasury, and the yield curve are the dominant macro variables for this name.
• However: CPI, core PCE, unemployment, fed funds rate, 10Y Treasury, and yield-curve data are all not available in provided documents (tool calls returned NO_DATA_AVAILABLE). No directional macro view can be responsibly stated for the past week.
• Prediction markets (Fed rate cut odds; recession 2026; office REIT / life science sector events): not available in provided documents.
• Practical consequence: the flow signal in Section 3 cannot be attributed to any macro driver. If rates moved materially during the past week, the desk has no visibility into it from the provided record — an explicit blind spot for a rate-sensitive REIT.

7. Actionable Insights & Trade Framing

1. Tactical tilt (low conviction, signal-only): The single freshest datapoint — QuantOrb CONTINUATION at MFI 67.02, strength 0.6251 (2026-09-17 session) — supports a short-horizon constructive bias on ARE flow. The document itself disclaims it as a screen output, not a recommendation. Appropriate only as a tilt, sized small, and only if the desk independently verifies current price/volume (not available in provided documents).
2. Do not build a fundamental position off this record. The newest fundamental filing is ~46 days old and contains no figures; the newest positioning data is ~5.5 months old. Any fundamental thesis requires the 2Q26 8-K's actual FFO/guidance/occupancy/disposition numbers — not available in provided documents.
3. Catalyst watch:
4. 3Q26 earnings (date not available in provided documents) — the key upcoming fundamental event; watch FFO/share and, per the supplemental's structure, the Guidance and Dispositions / Other Capital Sources sections.
5. Interim 8-Ks on dispositions/partial-interest sales or capital raising — a standing disclosure line for this issuer and directly relevant to funding the 3.5M RSF under-construction pipeline.
6. Next daily QuantOrb bake — confirmation or reversal of the 2026-09-17 CONTINUATION signal is the cheapest near-term check available.
7. Risk register (from documents):
8. Execution/capital risk: 3.5M RSF Class A/A+ under construction (~9.7% of operating RSF) must be leased and financed.
9. Concentration risk: dense geographic concentration in seven AAA life science clusters; tenant exposure to multinational pharma (extent truncated in excerpt).
10. Corroboration risk: one-session flow signal, unverified by news, macro, or price data.
11. Signal-type risk: MFI 67.02 is elevated on its scale; the document provides no overbought/oversold framework, so no reversal threshold can be stated.
12. Invalidation condition: A reversal in the next engine bake, any adverse company 8-K, or a fresh filing showing guidance pressure would flip the tactical read. None of these can be pre-scouted with the tools in this deployment.

8. Key Points Summary Table

Prepared 2026-09-18 for the ARE trading workflow. All quantitative citations trace to the four source documents; all gaps are explicitly labeled "not available in provided documents." External tool capability: all four assigned tools are disabled in this deployment (NO_DATA_AVAILABLE); re-run this analysis once market-data access is restored.

Fundamental Research Report: Alexandria Real Estate Equities Inc (ARE)

Report date: 2026-09-18 | Ticker: ARE (NYSE: ARE) | Sector: Real Estate | Industry: Office REITs

1. Data Access Notice (Tool Availability)

All four assigned tools were invoked for ARE — get_fundamentals, get_balance_sheet, get_cashflow, and get_income_statement — and all returned NO_DATA_AVAILABLE (external market data tools are disabled in this deployment). This report therefore relies exclusively on the four permitted source documents: the QuantOrb money-flow snapshot, the FY2025 10-K excerpt, the 2Q26 8-K press-release excerpt, and the 13F-HR institutional holdings snapshot. Where a data point is not covered by those documents, it is explicitly flagged below as "not available in provided documents."

2. Company Profile (Source: SEC 10-K, filed 2026-01-26)

• Legal/structural identity: Maryland corporation formed in October 1994, having elected to be taxed as a REIT for federal income tax purposes. Listed on NYSE under ARE and a member of the S&P 500.
• Business model: Alexandria is a life science REIT — described in the filing as "the preeminent and longest-tenured owner, operator, and developer of collaborative Megacampus™ ecosystems" — and the company that pioneered the life science real estate niche at its 1994 founding.
• Geographic footprint (AAA life science innovation clusters): Greater Boston, the San Francisco Bay Area, San Diego, Seattle, Maryland, Research Triangle, and New York City. This is a deliberately clustered, coastal-tier-1 asset base rather than a nationally diversified one.
• Tenant base: Multinational pharmaceutical companies and other life science tenants (the filing excerpt truncates the full tenant description).
• Scale, as of December 31, 2025:
• Total market capitalization: $20.75 billion
• Operating properties: 35.9 million RSF
• Class A/A+ properties under construction: 3.5 million RSF

Interpretation: ARE operates a build-and-lease development model at scale — roughly 9.7% of its operating square footage has a parallel construction pipeline (3.5M RSF under construction vs. 35.9M RSF operating), which is a structural growth lever but also a lease-up and capital-commitment risk vector that traders should monitor via the company's periodic supplemental packages.

3. Most Recent Financial Reporting: 2Q26 8-K (Source: SEC 8-K Item 2.02, filed 2026-08-03)

An 8-K Item 2.02 furnishing the Second Quarter Ended June 30, 2026 earnings press release and full supplemental package was filed on 2026-08-03. The provided excerpt is the table of contents only; the underlying figures are not available in provided documents. However, the document structure confirms the following disclosures exist and are the relevant items to pull for a complete fundamental read:

Specific 2Q26 figures — revenues, net income, FFO per share, occupancy, same-property NOI, guidance ranges, and balance sheet totals — are not available in provided documents.

4. Institutional Ownership Snapshot (Source: SEC 13F-HR, positions as of 2026-03-31)

The quantorb filers dataset tracks 5 institutional filer rows for ARE (a partial top-holder snapshot, not exhaustive; subject to a statutory reporting lag of up to 45 days from the 2026-03-31 snapshot date):

Reading: The tracked filers are split — the largest tracked holder (LaSalle) cut its position by 11.3% and IMS trimmed marginally, while all three smaller filers added aggressively (Town Lane +15.5%, Oak Thistle more than 5x its position, Voss Capital +66.7%). Note this data is stale (2026-03-31) and predates the 2Q26 report; it should be treated as background positioning context, not a current signal. Total shares outstanding, aggregate institutional ownership percentage, and any holders beyond these 5 rows are not available in provided documents.

5. Quantitative Money-Flow Signal (Source: QuantOrb money-flow engine, 2026-09-17 US session)

• MFI reading: 67.02 — on the higher end of the Money Flow Index range (a 0–100 oscillator), indicating comparatively strong money inflow pressure in the most recent session for which data exists.
• Signal: CONTINUATION with signal strength 0.6251 — the engine characterizes current flow as consistent with continuation of the prevailing move rather than a reversal setup.
• Critical framing (per the source): this is a quantitative screen output, not a recommendation, and it covers the 2026-09-17 US session (site bake of the 05:30 HKT orb run). It is the only datapoint in the provided set that is current to the past week.

6. Fundamental Timeline vs. the "Past Week" Window

Bottom line for the week: Per the provided documents, ARE generated no new fundamental filings during the past week. The freshest fundamental document remains the 2026-08-03 2Q26 8-K, and the freshest datapoint of any kind is the 2026-09-17 money-flow snapshot. Any current-quarter results (3Q26), updated guidance, occupancy, or dividend actions are not available in provided documents.

7. Key Fundamental Themes and Actionable Insights for Traders

1. Momentum context (primary actionable input this week): The 2026-09-17 MFI of 67.02 with a CONTINUATION signal (0.6251 strength) is the only current-week datapoint. For flow-sensitive traders it suggests inflow pressure consistent with trend continuation; it is a screen output and should be corroborated against price/volume and the full 2Q26 supplemental before acting.
2. Development pipeline is the fundamental swing factor: With 3.5M RSF of Class A/A+ product under construction against 35.9M RSF operating (as of 2025-12-31), lease-up pace and funding of that pipeline drive ARE's forward FFO trajectory. The 2Q26 supplemental contains dedicated sections ("Recent Deliveries," "Under Construction," "New Class A/A+ Development and Redevelopment Properties," and "Dispositions... and Other Capital Sources") — these are the exact pages to review for the growth/funding balance.
3. Guidance is the near-term catalyst: The 2Q26 8-K includes a Guidance section, but no guidance figures are available in provided documents. The next scheduled fundamental catalyst after 2026-08-03 would ordinarily be a 3Q26 report, but its date and any pre-announcement are not available in provided documents.
4. Mixed institutional hand (stale): The largest tracked 13F holder trimmed while three smaller tracked filers added materially as of 2026-03-31 — a split positioning picture that predates the 2Q26 report and should not be extrapolated.
5. Sector-specific risk framing: ARE carries the Office REITs industry tag in the QuantOrb snapshot; its fundamentals are tied to life science tenant demand, and its asset base is concentrated in seven AAA clusters. Tenant-level concentration, occupancy, and credit metrics are not available in provided documents and must be sourced from the full 2Q26 supplemental.
6. REIT distribution obligation: The 10-K confirms REIT tax election; current dividend level and payout coverage are not available in provided documents.

8. Explicit Data Gaps (not available in provided documents)

• 2Q26 revenues, net income, FFO and FFO per share, guidance ranges, occupancy, same-property NOI, lease terms, and balance-sheet totals (8-K excerpt contains only a table of contents)
• Total shares outstanding, aggregate institutional ownership %, and any 13F holders beyond the 5 tracked rows
• Share price, valuation multiples, dividend per share, credit metrics, and debt maturity schedule
• Any 3Q26 earnings date, subsequent filings after 2026-08-03, or corporate actions during the 2026-09-11 → 2026-09-18 week

9. Summary Table of Key Points

Overall assessment: The provided documents establish ARE's identity, scale, and development posture (as of 2025-12-31), a partially disclosed 2Q26 reporting event (2026-08-03), stale and mixed institutional positioning (2026-03-31), and one fresh quantitative flow datapoint (2026-09-17: MFI 67.02, CONTINUATION). A complete fundamental trade decision on ARE requires the full 2Q26 supplemental figures and current market data, which are not available in provided documents.